Wealth Fund Capital Invests in Wearable Nicotine Device
Posted on 09/09/2016
According to the Centers for Disease Control and Prevention, cigarette smoking kills more than 480,000 Americans per annum. A slew of investors are betting on a company that can successfully develop high-quality smoking-cessation wearable devices. Hayward, California-based Chrono Therapeutics Inc. raised US$ 47.6 million in a Series B round of capital. The lead investor in […]
- Alternatives
- Asia
- Chrono Therapeutics
- Kaiser Permanente Ventures
- Khazanah Nasional
- Malaysia
- Venture Capital
- Xeraya Capital